Company news
United Therapeutics Corporation news in 2019
United Therapeutics Corporation's news releases, calls and decks from 2019, newest first.
United Therapeutics Corporation Reports Third Quarter 2019 Financial Results
October 29, 2019
United Therapeutics Corporation to Report Third Quarter 2019 Financial Results Before the Market Opens on Wednesday, October 30, 2019
October 22, 2019
United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study
October 20, 2019
United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review
September 10, 2019
United Therapeutics Corporation To Present At 2019 Wedbush PacGrow Healthcare Conference
August 5, 2019
United Therapeutics Corporation To Report Second Quarter 2019 Financial Results Before The Market Opens On Wednesday, July 31, 2019
July 23, 2019
United Therapeutics Corporation to Present at Goldman Sachs 40th Annual Global Healthcare Conference
June 4, 2019
United Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference
May 27, 2019
United Therapeutics Announces FDA Approval Of XPS(TM) And Steen Solution(TM) Used To Perform Centralized Ex-Vivo Lung Perfusion Services
April 28, 2019
United Therapeutics Corporation To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019
April 23, 2019
United Therapeutics Issues Statement In Response To Meritless Lawsuit
April 16, 2019
United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint
April 7, 2019
Decks in 2019
- 13th PVRI World Congress 2019
Conference · 24 slides · Feb 1, 2019